--2023/Q28.258M / 10.254M--
--2023/Q18.832M / 9.197M--
--2022/Q49.807M / 12.730M--
--2022/Q310.022M / 10.028M--
--2022/Q28.448M / 8.519M--
US Stock MarketDetailed Quotes
RVLPQ RVL Pharmaceuticals
- 0.000
- 0.0000.00%
15min DelayClose Jul 26 09:30 ET
11.14KMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)111.41MShares0.03552wk High0.00P/B9.37KFloat Cap0.00052wk Low--Dividend TTM93.73MShs Float0.035Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
RVL Pharmaceuticals Key Stats
RVL Pharmaceuticals Earnings Date
Currency: USD
Period
Q2 FY2023 Earnings
--
Revenue(YoY)
8.26M
-2.25%EPS(YoY)
-0.24
-71.43%Analyst Rating
No Data
RVL Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg